Provided by Tiger Trade Technology Pte. Ltd.

ACTIVEPASSIVE INTERNATIONAL EQUITY ETF

39.30
+0.26550.68%
Post-market: 39.17-0.1255-0.32%19:30 EDT
Volume:73.28K
Turnover:2.88M
Market Cap:1.15B
PE:- -
High:40.05
Open:39.10
Low:39.10
Close:39.03
52wk High:40.20
52wk Low:33.59
Shares:29.35M
Float Shares:29.35M
Volume Ratio:0.80
T/O Rate:0.25%
Dividend:1.32
Dividend Rate:3.35%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Ascentage Pharma Corrects Timing for August 19, 2026 Interim Results Webcast

TIPRANKS
·
Aug 13

Copel Board Approves R$706 Million Interest on Equity and 2025 Form 20-F Filing

TIPRANKS
·
Aug 13

Asian Companies Raise $28 Billion via ADRs in 2024, Marking a Six-Year High, as AI Boom and Valuation Gaps Drive Listings

Stock News
·
Aug 13

Anheuser-Busch InBev S.A. ADR Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 13

New York Closing Stocks

Dow Jones
·
Aug 13

Stocks Ex-Dividend August 14

Dow Jones
·
Aug 13

European Stocks Decline as Middle East Tensions Overshadow Inflation Relief

Deep News
·
Aug 13

Haleon’s New Gum‑Health Toothpaste Trial: What Investors Should Watch

TIPRANKS
·
Aug 13

Cantor Fitzgerald Reaffirms Their Buy Rating on Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
Aug 12

Kaspi.kz Posts Strong H1 2026 Revenue Growth as Costs Hold Profit Flat

TIPRANKS
·
Aug 12

Yi Chen Raises Approval Odds and Lifts Tinlarebant-Focused 12‑Month Price Target to $214 While Reiterating Buy Rating

TIPRANKS
·
Aug 12

Contrasting Views on BOJ Policy May Undermine US-Japan Yen Rescue Efforts

Deep News
·
Aug 12

NYSE Net Change Percentage Gainers & Losers

Dow Jones
·
Aug 12

NYSE Most Active Issues

Dow Jones
·
Aug 12

Anheuser-Busch InBev S.A. ADR Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease

TIPRANKS
·
Aug 12

Cboe data shows mixed options sentiment in SK Hynix Inc – ADR with shares up 3.07%

TIPRANKS
·
Aug 12

European Stock Markets Largely Steady as Geopolitical Tensions Remain in Investor Focus

Deep News
·
Aug 12

Copel Board Approves Q2 2026 Results and BNDES-Backed R$4 Billion Financing Plan

TIPRANKS
·
Aug 12

Incannex Secures A$5.1M R&D Tax Incentive Refund

TIPRANKS
·
Aug 11